Literature DB >> 21565924

Association of the transfer coefficient of the lung for carbon monoxide with emphysema progression in male smokers.

F A A Mohamed Hoesein1, P Zanen, B van Ginneken, R J van Klaveren, J-W J Lammers.   

Abstract

A decreased transfer coefficient of the lung for carbon monoxide (K(CO)) is associated with emphysema. We evaluated whether in heavy smokers, baseline K(CO) was associated with the progression of computed tomography (CT)-detected emphysema, and the progression of airflow limitation. Heavy smokers, mean ± sd 41.3 ± 18.7 pack-yrs, participating in a lung cancer screening trial underwent diffusion testing and CT scanning of the lungs. CT scanning was repeated after median (25th-75th percentile) 2.8 (2.7-3.0) yrs and emphysema was assessed by lung densitometry using the 15th percentile. The association between K(CO) at baseline with progression of emphysema and lung function decline was assessed by multiple linear regression, correcting for baseline CT-quantified emphysema severity and forced expiratory volume in 1 s (FEV₁/forced vital capacity (FVC), age, height, body mass index, pack-yrs and smoking status (current or former smoker). 522 participants aged 60.1 ± 5.4 yrs were included. Mean ± sd 15th percentile was -938 ± 19, absolute FEV₁/FVC was 71.6 ± 9% and K(CO) was 1.23 ± 0.25, which is 81.8 ± 16.5% of predicted. By interpolation, a one sd (0.25) lower K(CO) value at baseline predicted a 1.6 HU lower 15th percentile and a 0.78% lower FEV₁/FVC after follow-up (p < 0.001). A lower baseline K(CO) value is independently associated with a more rapid progression of emphysema and airflow limitation in heavy smokers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565924     DOI: 10.1183/09031936.00050711

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

Review 1.  Lung densitometry: why, how and when.

Authors:  Mario Mascalchi; Gianna Camiciottoli; Stefano Diciotti
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

2.  Percent emphysema and right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis-Lung and Multi-Ethnic Study of Atherosclerosis-Right Ventricle Studies.

Authors:  Maria Grau; R Graham Barr; Joao A Lima; Eric A Hoffman; David A Bluemke; J Jeffrey Carr; Harjit Chahal; Paul L Enright; Aditya Jain; Martin R Prince; Steven M Kawut
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

3.  Optimal threshold in CT quantification of emphysema.

Authors:  Zhimin Wang; Suicheng Gu; Joseph K Leader; Shinjini Kundu; John R Tedrow; Frank C Sciurba; David Gur; Jill M Siegfried; Jiantao Pu
Journal:  Eur Radiol       Date:  2012-11-01       Impact factor: 5.315

4.  Aging-related systemic manifestations in COPD patients and cigarette smokers.

Authors:  Laurent Boyer; Christos Chouaïd; Sylvie Bastuji-Garin; Elisabeth Marcos; Laurent Margarit; Philippe Le Corvoisier; Laetitia Vervoitte; Leila Hamidou; Lamia Frih; Etienne Audureau; Ala Covali-Noroc; Pascal Andujar; Zakaria Saakashvili; Anne Lino; Bijan Ghaleh; Sophie Hue; Geneviève Derumeaux; Bruno Housset; Jean-Luc Dubois-Randé; Jorge Boczkowski; Bernard Maitre; Serge Adnot
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 5.  Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.

Authors:  Andrea Rossi; Bojana Butorac-Petanjek; Marco Chilosi; Borja G Cosío; Matjaz Flezar; Nikolaos Koulouris; José Marin; Neven Miculinic; Guido Polese; Miroslav Samaržija; Sabina Skrgat; Theodoros Vassilakopoulos; Andrea Vukić-Dugac; Spyridon Zakynthinos; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-29

6.  Evaluation of pulmonary function using single-breath-hold dual-energy computed tomography with xenon: Results of a preliminary study.

Authors:  Hiroyuki Kyoyama; Yusuke Hirata; Satoshi Kikuchi; Kosuke Sakai; Yuriko Saito; Shintaro Mikami; Gaku Moriyama; Hisami Yanagita; Wataru Watanabe; Katharina Otani; Norinari Honda; Kazutsugu Uematsu
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

7.  Cardiovascular risk in patients with alpha-1-antitrypsin deficiency.

Authors:  Sebastian Fähndrich; Frank Biertz; Annika Karch; Björn Kleibrink; Armin Koch; Helmut Teschler; Tobias Welte; Hans-Ulrich Kauczor; Sabina Janciauskiene; Rudolf A Jörres; Timm Greulich; Claus F Vogelmeier; Robert Bals
Journal:  Respir Res       Date:  2017-09-15

8.  Rate of progression of CT-quantified emphysema in male current and ex-smokers: a follow-up study.

Authors:  Firdaus A A Mohamed Hoesein; Pieter Zanen; Pim A de Jong; Bram van Ginneken; H Marike Boezen; Harry J M Groen; Mathijs Oudkerk; Harry J de Koning; Dirkje S Postma; Jan-Willem J Lammers
Journal:  Respir Res       Date:  2013-05-20

9.  Computed tomography structural lung changes in discordant airflow limitation.

Authors:  Firdaus A A Mohamed Hoesein; Pim A de Jong; Jan-Willem J Lammers; Willem Pthm Mali; Michael Schmidt; Harry J de Koning; Carlijn van der Aalst; Matthijs Oudkerk; Rozemarijn Vliegenthart; Bram van Ginneken; Eva M van Rikxoort; Pieter Zanen
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

10.  Protocol for the EARCO Registry: a pan-European observational study in patients with α1-antitrypsin deficiency.

Authors:  Timm Greulich; Alan Altraja; Miriam Barrecheguren; Robert Bals; Jan Chlumsky; Joanna Chorostowska-Wynimko; Christian Clarenbach; Luciano Corda; Angelo Guido Corsico; Ilaria Ferrarotti; Cristina Esquinas; Caroline Gouder; Ana Hećimović; Aleksandra Ilic; Yavor Ivanov; Sabina Janciauskiene; Wim Janssens; Malcolm Kohler; Alvils Krams; Beatriz Lara; Ravi Mahadeva; Gerry McElvaney; Jean-François Mornex; Karen O'Hara; David Parr; Eava Piitulainen; Karin Schmid-Scherzer; Niels Seersholm; Robert A Stockley; Jan Stolk; Maria Sucena; Hanan Tanash; Alice Turner; Ruxandra Ulmeanu; Marion Wilkens; Arzu Yorgancioğlu; Ana Zaharie; Marc Miravitlles
Journal:  ERJ Open Res       Date:  2020-03-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.